TRIM33 and scleroderma: The results from our review, which included patients from Kubo et al., demonstrate numerous nailfold capillaroscopic abnormalities in patients positive for anti-MDA5 and anti-TIF1-γ, with both groups containing a number of individuals with scleroderma-spectrum abnormalities.